Inhibitors of nucleic acid synthesis: biophysical and biochemical aspects.
D000546:Amanitins / Q000494:pharmacology; D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001761:Bleomycin / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D004214:Distamycins / Q000494:pharmacology; D004486:Edeine / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology; D008926:Plicamycin / Q000494:pharmacology; D011809:Quinones / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology; D013308:Streptonigrin / Q000494:pharmacology; D013698:Templates, Genetic; D014158:Transcription, Genetic / Q000187:drug effects*; D009353:Zinostatin / Q000494:pharmacology
D000546:Amanitins; D000596:Amino Acids; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D004214:Distamycins; D008937:Mitomycins; D009705:Nucleosides; D011809:Quinones; D012294:Rifamycins; D004486:Edeine; D001761:Bleomycin; D003609:Dactinomycin; D013308:Streptonigrin; D009268:Nalidixic Acid; D009353:Zinostatin; D012321:DNA-Directed RNA Polymerases; D008926:Plicamycin